L Valeyrie-Allanore
Overview
Explore the profile of L Valeyrie-Allanore including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
965
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lefaucheur J, Hajj C, Valeyrie-Allanore L, Colin A, Ng Wing Tin S, de Prost N, et al.
J Eur Acad Dermatol Venereol
. 2020 Sep;
35(3):e218-e221.
PMID: 32920914
No abstract available.
2.
Lefaucheur J, Valeyrie-Allanore L, Ng Wing Tin S, Abgrall G, Colin A, Hajj C, et al.
J Eur Acad Dermatol Venereol
. 2020 Aug;
35(1):188-194.
PMID: 32810314
Background: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are associated with various sequelae. Chronic pain, one of these sequelae, has never been systematically evaluated. Objectives And Methods: To assess...
3.
Ingen-Housz-Oro S, Assier H, Gener G, Milpied B, Soria A, Bernier C, et al.
Ann Dermatol Venereol
. 2019 Mar;
146(4):313-318.
PMID: 30904277
No abstract available.
4.
Hefez L, Zaghbib K, Sbidian E, Valeyrie-Allanore L, Allain M, Duong T, et al.
Br J Dermatol
. 2018 Oct;
180(5):1206-1213.
PMID: 30282109
Background: Epidermal necrolysis is a rare and severe cutaneous adverse reaction to drugs with long-term somatic consequences and potentially underrecognized psychological complications. Objectives: To assess the prevalence and risk factors...
5.
Bardo-Brouard P, Luizard C, Valeyrie-Allanore L, Goujon C, Do B, Colin A, et al.
Curr Med Res Opin
. 2018 Jan;
34(5):887-891.
PMID: 29368950
Aim: The aim of this case series was to report the use of 8% topical capsaicin patch (marketed under the trade name Qutenza) in the management of refractory neuropathic pain...
6.
Chaby G, Valeyrie-Allanore L, Duong T, Lebrun-Vignes B, Milpied B, Sassolas B, et al.
Br J Dermatol
. 2018 Jan;
179(2):329-336.
PMID: 29352771
Background: The proportion of severe cutaneous adverse reactions (SCARs) that could be avoided if medication use was consistent with good medical practice is unknown. Objectives: To estimate the proportion of...
7.
Viarnaud A, Ingen-Housz-Oro S, Marque M, Valeyrie-Allanore L, Ortonne N, Gueudry J, et al.
J Eur Acad Dermatol Venereol
. 2017 Jul;
32(1):e34-e36.
PMID: 28710842
No abstract available.
8.
Papo M, Valeyrie-Allanore L, Razazi K, Carteaux G, Wolkenstein P, Chosidow O, et al.
Br J Dermatol
. 2016 Aug;
176(5):1370-1372.
PMID: 27510226
No abstract available.
9.
Salle de Chou C, Ortonne N, Hivelin M, Wolkenstein P, Chosidow O, Valeyrie-Allanore L
Ann Dermatol Venereol
. 2016 Feb;
143(2):139-43.
PMID: 26852214
Background: Inflammatory bowel diseases are associated with a broad range of cutaneous lesions. Herein we report the first case of aseptic skin abscesses associated with ulcerative colitis. Case Report: Since...
10.
Valeyrie-Allanore L
Ann Dermatol Venereol
. 2016 Jan;
142 Suppl 3:S1-7.
PMID: 26792410
Significant advances have been performed in cutaneous adverse reactions leading to primary prevention strategy and implication of new signaling pathways. Histological features of DRESS and methotrexate toxicity are detailed. New...